Today, the FDA approved a treatment to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Read more: FDA Approves Treatment for Chronic Kidney Disease